Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Influenza virus NS1A-binding protein is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
IVNS1ABP |
Gene ID: |
10625 |
Uniprot ID: |
NS1BP_HUMAN |
Specificity: |
This antibody detects endogenous levels of IVNS1ABP at Human, Mouse |
Immunogen: |
Synthesized peptide derived from human IVNS1ABP |
Protein Name | Influenza Virus Ns1a-Binding ProteinNs1-BpNs1-Binding ProteinAryl Hydrocarbon Receptor-Associated Protein 3Kelch-Like Protein 39 |
Cellular Localisation | CytoplasmCytoskeletonNucleusNucleoplasmAssociated With Actin FilamentsLocalization Related To Speckle Domains Which Correspond To Interchromatin Granules And Are Enriched In Factors Involved In Pre-Mrna SplicingFollowing Influenza A Virus InfectionRedistribution From Speckles To A More Diffuse Distribution In The Nucleoplasm |
Alternative Antibody Names | Anti-Influenza Virus Ns1a-Binding Protein antibodyAnti-Ns1-Bp antibodyAnti-Ns1-Binding Protein antibodyAnti-Aryl Hydrocarbon Receptor-Associated Protein 3 antibodyAnti-Kelch-Like Protein 39 antibodyAnti-IVNS1ABP antibodyAnti-ARA3 antibodyAnti-FLARA3 antibodyAnti-KIAA0850 antibodyAnti-KLHL39 antibodyAnti-NS1 antibodyAnti-NS1BP antibodyAnti-HSPC068 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance